Health insurers: Mind your own business!

Article Highlights

  • The MLR rule signifies a belief, now enshrined in legislation, that health insurance markets do not work.

    Tweet This

  • Health insurers are reacting to the #ACA with lockstep acquisitions – of each other, providers, and other businesses.

    Tweet This

  • Horizontal consolidation in health care will further reduce competition and the pressure to lower medical costs.

    Tweet This

  • Insurers are putting their considerable capital/talent into what? Acquiring each other & contacts lens companies. Wow.

    Tweet This

You may have received a refund check in the past few months from your health insurer. This is not your individual reward for staying healthy; it is your insurer's punishment for making too much money because you did.

Obamacare includes what the health care technocracy calls the "MLR rule" - minimum requirements for medical-loss ratios - or the percentage of premiums collected by health insurers that must be spent on medical care or refunded. The inverse of the MLR is the percentage spent on administration and marketing, and earned as profit. Obamacare sets minimum MLRs of 80 percent for individual and small group plans, and 85 percent for large groups.

Aside from its obvious populist appeal, this profit regulation mechanism signifies a belief, now enshrined in legislation, that health insurance markets do not work. Without such a rule, the architects of Obamacare believe, insurers can name their prices, however inflated, and we all just pay.

"Aside from its obvious populist appeal, this profit regulation mechanism signifies a belief, now enshrined in legislation, that health insurance markets do not work." -J.D. KleinkeIn the short term, that is true. Most health insurance plans price only once per year, are subject to long delays in cost trending information and multi-year underwriting cycles, and endure the meddling of a carnival midway's worth of employee benefits tinkerers, agents, brokers, consultants, and other conflicted middlemen. But in the long term, over multiple annual cycles, premiums do rise and fall, and the health insurance industry's fortunes with them.

The MLR rule may well put an end to these admittedly slow, imperfect self-correcting market forces. Under Obamacare, the industry is transfigured from an inefficient, barely competitive mess that tries, against the laws of health care gravity, to control medical costs, to a non-competitive, profit-regulated utility rewarded with 15 to 20 extra cents for every dollar it allows its medical costs to rise.

What would any rational firm in a slow-motion marketplace do when it faces a new lockdown rate on its administrative and marketing costs and profits? First, find ways to let the cost basis for the lockdown rise, i.e., let medical costs inch up. Then acquire competitors to minimize friction for the strategy. Finally, buy up suppliers - i.e., those generating the bulk of medical costs, namely hospitals and doctors - so as to capture what would have been capped margins upstream of the insurer's MLR calculation.

Retail Therapy for Anxious Insurers

Such acquisitions constitute the deal flow of health insurers since the weight of Obamacare started to hit their income statements this summer. As an encore, they are also dumping billions of shareholders' capital into all manner of adjacent businesses, believing they can cross-sell products and services to their customers free of the MLR regulation, e.g., Wellpoint's nearly $900 million purchase in June of 1-800 Contacts.

Health insurers are reacting to Obamacare the same way they did to the last assault on their profit margins, managed care in the 1990s, with lockstep acquisitions - of each other, of providers, and of businesses with often tenuous relevance to their core competencies. Last month, Wellpoint agreed to pay $4.5 billion for Amerigroup. Last week, Aetna purchased Coventry for $5.7 billion. This is probably just the ante; the stocks of health insurers have taken a pounding since the Supreme Court upheld Obamacare, making them easier targets, and when more than one major insurer moves, many follow.

In addition to such horizontal consolidation, which will further reduce competition and the pressure to lower medical costs, insurers are also buying "vertically" - purchasing hospitals and physician practices around the country. There is much happy talk surrounding these deals about "care integration" and "accountable care" - the same sort of hooey that accompanied these such deals in the 1990s - and they will inevitably blow up in execution because of the same strategic and cultural conflicts. The most spectacularly messy version, so far: Highmark BlueCross' purchase of the second biggest hospital system in western Pennsylvania, a deal in all manner of trouble before it even closed.

The real goal of these deals: the health insurer wants to shift profits out from under the MLR rule, and pick them back up on the provider business - essentially re-locating margins from the regulated to the unregulated part of their portfolio. Good luck with that new hospital business under the current regulatory regime and imminent Medicare financing meltdown.

If health insurers wanted to protect their shareholders long term under the new Obamacare order, they would invest not in these desperate fantasies of market control, but in their own operations. "Managed care" may have come and gone but the myriad problems in the medical delivery system it tried to fix have not.

Where to start? Today's scandal au courant in dangerous medical excess is coronary stents - tiny wire devices implanted in coronary arteries - a cash cow business for hospitals that pose great risk to patients, many of whom, it turns out, do not need them. Where else? Though the media has tired of talking about it, the related epidemics of obesity and diabetes rage on. And all the perennial problems associated with sprawling cancer treatments, under-medicated diseases, over-medicated nonsense, and needless interventions at both the beginning and end of life are screaming for the rationalization that only a health insurer can bring to bear on a money-driven delivery system.

And yet the insurers put their considerable capital and talent into what? Acquiring each other. And contacts lens companies. Wow.

The insurers would be better served minding their real business: managing the medical costs and health status of those they insure. There are no fancy tricks or world-beater press releases for this - just lots of hard work adjudicating claims, rooting out fraud, aligning payment with evidence, managing provider and patient adherence to the evidence, tracking outcomes, and steering people toward the better hospitals and doctors. These are the mostly untried but still true great ideas from the past two decades that everyone likes to talk about, but almost no one gets around to executing.

Perhaps because such execution is hard work. Buying and selling businesses has always been more fun than creating, growing, and running them - especially when confronted by market-distorting garbage like the MLR rule, which is designed specifically to punish those businesses for their success.

 

J.D. Kleinke is a Resident Fellow at the American Enterprise Institute. He is a medical economist, a former healthcare executive, and the author of three books about healthcare and medicine.

Also Visit
AEIdeas Blog The American Magazine
About the Author

 

J.D.
Kleinke
  • J. D. Kleinke, an expert on health care business strategy and entrepreneurship, was instrumental in the creation of four health care information organizations. He has also advised established and start-up companies on health care business, product and technology strategy. Mr. Kleinke writes on the business of health care, health insurance and benefits as well as about doctors and the culture of medicine. His books include Bleeding Edge: The Business of Health Care in the New Century (Jones & Bartlett Learning, 1998), Oxymorons: The Myth of a U.S. Health Care System (Jossey-Bass, 2001), and Catching Babies (Fourth Chapter Books, 2011). At AEI, he is studying the interplay between health policy, health care market dynamics and health venture formation; the influence of information technology and medical technology on the overall health economy; and the impact of medical culture on health care organizations, markets and public health.

  • Phone: 202 862 5846
    Email: jd.kleinke@aei.org
  • Assistant Info

    Name: Catherine Griffin
    Phone: 202 862 5920
    Email: catherine.griffin@aei.org

What's new on AEI

image Recovering from tax time blues
image 10 welfare reform lessons
image Let HHS nominee Sylvia Burwell explain Obamacare lie
image Why bold ideas backfire in politics
AEI on Facebook
Events Calendar
  • 14
    MON
  • 15
    TUE
  • 16
    WED
  • 17
    THU
  • 18
    FRI
Wednesday, April 16, 2014 | 10:00 a.m. – 11:00 a.m.
Calling treason by its name: A conversation with Liam Fox

Join us at AEI as the Right Honorable Liam Fox sits down with Marc Thiessen to discuss and debate whether America’s intelligence agencies have infringed on the personal privacy of US citizens.

Event Registration is Closed
Thursday, April 17, 2014 | 4:00 p.m. – 5:00 p.m.
The curmudgeon's guide to getting ahead

How can young people succeed in workplaces dominated by curmudgeons who are judging their every move? At this AEI book event, bestselling author and social scientist Charles Murray will offer indispensable advice for navigating the workplace, getting ahead, and living a fulfilling life.

No events scheduled this day.
No events scheduled this day.
No events scheduled this day.
No events scheduled this day.
No events scheduled this day.
No events scheduled this day.